(dp1
S'10.1016/j.ijid.2006.09.010'
p2
(lp3
S'nasal vaccine candidate'
p4
aS'nasal vaccine'
p5
aS'healthy adults'
p6
aS'adverse events were'
p7
aS'7 15 30'
p8
aS'30 and 60'
p9
aS'0 7 15'
p10
aS'Adverse events were'
p11
aS'nasal'
p12
aS'trial'
p13
aS'HBsAg and HBcAg'
p14
aS'hepatitis B virus'
p15
aS'data collection sheets'
p16
aS'placebo group'
p17
aS'anti HBc antibodies'
p18
aS'30 days after'
p19
aS'anti HBs antibody'
p20
asS'10.1016/j.bbamcr.2008.02.002'
p21
(lp22
S'fission yeast'
p23
aS'death in fission'
p24
aS'lipotoxic cell death'
p25
aS'et al submitted'
p26
aS'Low et al'
p27
aS'al submitted manuscript'
p28
aS'Programmed cell death'
p29
aS'induced cell death'
p30
aS'fission'
p31
aS'cell death'
p32
aS'lipid induced cell'
p33
aS'budding yeast'
p34
aS'loss of viability'
p35
aS'PCD in fission'
p36
aS'lipid mediated signaling'
p37
aS'chronological and replicative'
p38
aS'cell death pathways'
p39
asS'10.1016/S0306-4565(01)00023-7'
p40
(lp41
S'semi supine'
p42
aS'cutaneous blood flow'
p43
aS'evaporative heat loss'
p44
aS'course of mean'
p45
aS'temperature regulation'
p46
aS'semi supine posture'
p47
aS'Student s paired'
p48
aS'supine and semi'
p49
aS'SEM Difference between'
p50
aS'supine and supine'
p51
aS'regulation in humans'
p52
aS'semi'
p53
aS'selective brain cooling'
p54
aS'than in semi'
p55
aS'both postural conditions'
p56
aS'influence'
p57
aS'than in supine'
p58
asS'10.1016/j.cpr.2011.03.004'
p59
(lp60
S'eating disorders'
p61
aS'need for treatment'
p62
aS'treatment seeking'
p63
aS'disorder specific treatment'
p64
aS'eating disorder specific'
p65
aS'eating disorder'
p66
aS'treatment for weight'
p67
aS'eating'
p68
aS'systematic review'
p69
aS'diagnosable eating disorder'
p70
aS'community cases'
p71
aS'mental health care'
p72
aS'proportion seeking treatment'
p73
aS'individuals with eating'
p74
aS'participants seeking treatment'
p75
aS'eating disorder screening'
p76
aS'likely to receive'
p77
asS'10.1016/S0002-8223(95)00279-0'
p78
(lp79
S'receiving nutrition advice'
p80
aS'prenatal care'
p81
aS'mothers reported receiving'
p82
aS'Live Birth File'
p83
aS'advice by maternal'
p84
aS'Infant Death File'
p85
aS'breast feeding'
p86
aS'prenatal'
p87
aS'mothers receiving'
p88
aS'among live births'
p89
aS'maternal characteristics among'
p90
aS'Table 1 Percent'
p91
aS'n 9 639'
p92
aS'mothers receiving nutrition'
p93
aS'characteristics among live'
p94
aS'weighted of mothers'
p95
aS'1 Percent weighted'
p96
asS'10.1016/j.tetlet.2008.02.043'
p97
(lp98
S'crystallization of membrane'
p99
aS'two dimensional crystallization'
p100
aS'two dimensional'
p101
aS'surface tension value'
p102
aS'membrane'
p103
aS'two'
p104
aS'membrane proteins'
p105
aS'presence of detergent'
p106
aS'protein'
p107
aS'fluid at 20'
p108
aS'Langmuir film'
p109
aS'lipid monolayer'
p110
aS'surface tension'
p111
aS'up of one'
p112
aS'one fluorinated chain'
p113
aS'fluorinated chain linked'
p114
aS'able to complex'
p115
asS'10.1016/B978-012373962-9.00410-6'
p116
(lp117
S'development and archaeology'
p118
aS'development enterprise'
p119
aS'intersection of both'
p120
aS'reproduction of old'
p121
aS'disciplinary interests belies'
p122
aS'much broader structural'
p123
aS'broader structural apparatus'
p124
aS'both disciplinary interests'
p125
aS'fears and exclusion'
p126
aS'cultural values without'
p127
aS'only oppressed ones'
p128
aS'able to espouse'
p129
aS'slightly differing manner'
p130
aS'distribution of resources'
p131
aS'slightly different ways'
p132
aS'all native communities'
p133
aS'identification and distribution'
p134
asS'10.1037/0003-066X.33.9.821'
p135
(lp136
S'psychotherapy research'
p137
aS'psychotherapy'
p138
aS'need to control'
p139
aS'authors suggest'
p140
aS'placebo'
p141
aS'inert procedure without'
p142
aS'control for such'
p143
aS'ref PsycINFO Database'
p144
aS'available therapies component'
p145
aS'placebo effect rubric'
p146
aS'condition being treated'
p147
aS'without specific activity'
p148
aS'contact and therapist'
p149
aS'term placebo group'
p150
aS'controls in psychotherapy'
p151
aS'discussed 26 ref'
p152
aS'psychotherapy placebo group'
p153
asS'10.1016/0014-5793(96)00063-4'
p154
(lp155
S'2 D crystallisation'
p156
aS'crystallisation of membrane'
p157
aS'16 kDa protein'
p158
aS'membrane proteins'
p159
aS'membrane'
p160
aS'16 kDa'
p161
aS'formation of vesicle'
p162
aS'Electron microscopical analysis'
p163
aS'2 D crystals'
p164
aS'nm with 90'
p165
aS'type H ATPase'
p166
aS'90 and p4'
p167
aS'vesicle like structures'
p168
aS'ammonium perfluoroocanoate APFO'
p169
aS'p4 projection symmetry'
p170
aS'sheets from solutions'
p171
aS'0 2 nm'
p172
asS'10.1016/j.cmpb.2009.03.005'
p173
(lp174
S'vertebral body mesh'
p175
aS'C4 C5 FSU'
p176
aS'spine'
p177
aS'finite element models'
p178
aS'C4 C5'
p179
aS'vertebral body'
p180
aS'left lateral bending'
p181
aS'posterior region'
p182
aS'body and posterior'
p183
aS'moment with 73'
p184
aS'meshing'
p185
aS'C5 FSU mesh'
p186
aS'cervical spine'
p187
aS'functional spinal unit'
p188
aS'posterior BB structure'
p189
aS'posterior'
p190
aS'literature'
p191
asS'10.1016/j.ygeno.2007.07.010'
p192
(lp193
S'gene strand bias'
p194
aS'gene strand'
p195
aS'gene strand preference'
p196
aS'bias in prokaryotic'
p197
aS'determination of gene'
p198
aS'regarding gene strand'
p199
aS'gene'
p200
aS'leading strand'
p201
aS'Pearson s correlation'
p202
aS'Supplementary data'
p203
aS's correlation coefficient'
p204
aS'differences in gene'
p205
aS'number of genes'
p206
aS'genome organization'
p207
aS'correlation coefficient between'
p208
aS'patterns of gene'
p209
aS'genome'
p210
asS'10.1016/S0021-9290(06)83053-8'
p211
(lp212
S'hip'
p213
aS'model for hip'
p214
aS'hip fracture'
p215
aS'parameterized finite element'
p216
aS'finite element model'
p217
aS'prediction'
p218
aS'parameterized'
p219
aS'element'
p220
aS'parameterized finite'
p221
aS'fracture prediction'
p222
aS'finite element'
p223
aS'fracture'
p224
aS'hip fracture prediction'
p225
aS'model'
p226
aS'finite'
p227
aS'element model'
p228
asS'10.1016/0163-7258(88)90016-2'
p229
(lp230
S'temperature regulation'
p231
aS'evidence'
p232
aS'system theoretical'
p233
aS'temperature regulation adaptation'
p234
aS'adaptation'
p235
aS'regulation adaptation'
p236
aS'Complementary system theoretical'
p237
aS'temperature'
p238
aS'Complementary'
p239
aS'system'
p240
aS'regulation'
p241
aS'fever Complementary'
p242
aS'theoretical'
p243
aS'fever'
p244
aS'experimental evidence'
p245
aS'mechanisms'
p246
aS'adaptation and fever'
p247
asS'10.1016/S1359-0294(01)00107-8'
p248
(lp249
S'integral membrane proteins'
p250
aS'integral membrane'
p251
aS'membrane protein crystallization'
p252
aS'crystallization of integral'
p253
aS'three dimensional'
p254
aS'dimensional membrane protein'
p255
aS'three dimensional membrane'
p256
aS'three dimensional crystals'
p257
aS'X ray crystallography'
p258
aS'three dimensional crystallization'
p259
aS'integral'
p260
aS'membrane proteins'
p261
aS'determination of phase'
p262
aS'three'
p263
aS'crystallization'
p264
aS'improve crystal quality'
p265
aS'X ray'
p266
asS'10.1016/j.jada.2006.08.007'
p267
(lp268
S'gestational weight gain'
p269
aS'excessive gestational weight'
p270
aS'prenatal nutrition interventions'
p271
aS'inadequate and excessive'
p272
aS'Social Cognitive Theory'
p273
aS'excessive gestational'
p274
aS'education and counseling'
p275
aS'appropriate gestational weight'
p276
aS'Institute of Medicine'
p277
aS'both inadequate'
p278
aS'among pregnant adolescents'
p279
aS'nutrition education'
p280
aS'uoi B758G 4M9NHJD'
p281
aS'prenatal nutrition'
p282
aS'among pregnant teens'
p283
aS'effect on birth'
p284
aS'highest risk'
p285
asS'10.1016/j.ridd.2011.07.018'
p286
(lp287
S'imitation and requesting'
p288
aS'Down syndrome'
p289
aS'toddlers with Down'
p290
aS'children with Down'
p291
aS'Down syndrome behavioral'
p292
aS'syndrome behavioral phenotype'
p293
aS'during baseline intervention'
p294
aS'Down'
p295
aS'request social interaction'
p296
aS'forms of requesting'
p297
aS'intervention and maintenance'
p298
aS'strengths in social'
p299
aS'independent correct requests'
p300
aS'requesting'
p301
aS'opportunity each session'
p302
aS'Cumulative independent correct'
p303
aS'first opportunity each'
p304
asS'10.1016/j.jbiomech.2004.11.014'
p305
(lp306
S'young normal cervical'
p307
aS'flexion extension'
p308
aS'young normal'
p309
aS'flexion'
p310
aS'cervical spinal segments'
p311
aS'cervical spine'
p312
aS'young'
p313
aS'flexibility in flexion'
p314
aS'flexion extension curves'
p315
aS'flexion extension data'
p316
aS'present study'
p317
aS'direction of loading'
p318
aS'flexion than'
p319
aS'normal cervical spines'
p320
aS'flexibility in extension'
p321
aS'than in extension'
p322
aS'6 and C7'
p323
asS'10.1016/0014-5793(85)80111-3'
p324
(lp325
S'membrane protein crystallization'
p326
aS'membrane protein'
p327
aS'nonionic surfactant'
p328
aS'polyethylene glycol'
p329
aS'surfactant'
p330
aS'salt'
p331
aS'membrane'
p332
aS'nonionic'
p333
aS'polyethylene'
p334
aS'micellar oligooxyethylene chains'
p335
aS'nonionic surfactant CE'
p336
aS'lower temperatures without'
p337
aS'configurational interaction between'
p338
aS'used in membrane'
p339
aS'While sodium chloride'
p340
aS'compared Micellar systems'
p341
aS'lower consolution boundary'
p342
asS'10.1016/S0188-4409(03)00069-9'
p343
(lp344
S'body fat pattern'
p345
aS'low income'
p346
aS'incidence and progression'
p347
aS'body fat'
p348
aS'grade 1 obesity'
p349
aS'overweight and obesity'
p350
aS'body mass index'
p351
aS'progression of obesity'
p352
aS'Mexico'
p353
aS'first follow up'
p354
aS'obesity'
p355
aS'mean waist circumference'
p356
aS'follow up phases'
p357
aS'Mexico City'
p358
aS'fat pattern distribution'
p359
aS'Mexican population'
p360
aS'99 70 44'
p361
asS'10.1016/j.medengphy.2010.03.001'
p362
(lp363
S'finite element model'
p364
aS'spine finite element'
p365
aS'cervical spine finite'
p366
aS'finite element'
p367
aS'bending and axial'
p368
aS'cervical spine'
p369
aS'Experimental and computational'
p370
aS'extension lateral bending'
p371
aS'flexion extension lateral'
p372
aS'1 0Nm'
p373
aS'specimen specific'
p374
aS'right and left'
p375
aS'axial rotation'
p376
aS'finite'
p377
aS'finite element coupled'
p378
aS'C2 C7 model'
p379
aS'experimental loading curves'
p380
asS'10.1016/j.actbio.2011.06.002'
p381
(lp382
S'tendon and ligament'
p383
aS'collagen fibre'
p384
aS'Adapted from Ref'
p385
aS'used with permission'
p386
aS'Ref and used'
p387
aS'collagen fibre biomaterials'
p388
aS'ligament and tendon'
p389
aS'collagen fibre scaffolds'
p390
aS'collagen'
p391
aS'ligament'
p392
aS'tendon'
p393
aS'Kato et al'
p394
aS'collagen fibres'
p395
aS'using collagen fibre'
p396
aS'embedded collagen fibres'
p397
aS'Scale bar 20'
p398
aS'20 m Adapted'
p399
asS'10.1016/j.jbiomech.2009.04.007'
p400
(lp401
S'lower cervical spine'
p402
aS'geometrical parameters'
p403
aS'subject specific'
p404
aS'lower cervical'
p405
aS'C5 C6 functional'
p406
aS'specific finite element'
p407
aS'subject specific finite'
p408
aS'finite element models'
p409
aS'motion patterns'
p410
aS'C6 functional units'
p411
aS'parametric and subject'
p412
aS'ranges of motion'
p413
aS'biplanar X rays'
p414
aS'subject specific modelling'
p415
aS'cervical spine'
p416
aS'geometrical'
p417
aS'16 C5 C6'
p418
asS'10.1016/S1937-6448(08)01403-2'
p419
(lp420
S'induced cell death'
p421
aS'types of ROS'
p422
aS'cell death network'
p423
aS'plant cell death'
p424
aS'PCD in plants'
p425
aS'oxygen species ROS'
p426
aS'aspects of plant'
p427
aS'growth and development'
p428
aS'HO induced cell'
p429
aS'plant PCD'
p430
aS'HO and other'
p431
aS'nitrogen species RNS'
p432
aS'reactive nitrogen species'
p433
aS'ROS and reactive'
p434
aS'reactive oxygen species'
p435
aS'cell death regulators'
p436
aS'O and HO'
p437
asS'10.1016/S0959-440X(02)00354-8'
p438
(lp439
S'membrane proteins'
p440
aS'belong to space'
p441
aS'coloured in blue'
p442
aS'fragment mediated crystallisation'
p443
aS'antibody fragments'
p444
aS'membrane'
p445
aS'Antibody fragment mediated'
p446
aS'coloured in green'
p447
aS'three dimensional crystals'
p448
aS'fragments in red'
p449
aS'fragment PDB code'
p450
aS'detergent micelle'
p451
aS'fragment co complex'
p452
aS'streptavidin affinity chromatography'
p453
aS'integral membrane protein'
p454
aS'antibody Fv fragment'
p455
aS'Fv fragment Fv'
p456
asS'10.1016/S1048-6666(06)80095-9'
p457
(lp458
S'ligament augmentation device'
p459
aS'cruciate ligament reconstruction'
p460
aS'anterior cruciate ligament'
p461
aS'ligament augmentation'
p462
aS'ligament'
p463
aS'knee with full'
p464
aS'load sharing Adherence'
p465
aS'strong to allow'
p466
aS'principle of load'
p467
aS'precise surgical technique'
p468
aS'arthroscopically assisted technique'
p469
aS'Adherence to standard'
p470
aS'synthetically augmented semitendinosus'
p471
aS'assisted anterior cruciate'
p472
aS'range of motion'
p473
aS'ligament reconstruction may'
p474
aS'torn assisted anterior'
p475
asS'10.1016/S0968-0160(96)00242-6'
p476
(lp477
S'ABC prosthetic ligament'
p478
aS'ABC prosthetic'
p479
aS'patients had reconstruction'
p480
aS'patellar tendon'
p481
aS'ABC'
p482
aS'prosthetic ligament'
p483
aS'prosthetic'
p484
aS'any accelerated rehabilitation'
p485
aS'assess any early'
p486
aS'compared to autologous'
p487
aS'cannot therefore justify'
p488
aS'Patellar tendon replacement'
p489
aS'lag and pain'
p490
aS'any early advantage'
p491
aS'third Patellar tendon'
p492
aS'prosthetic ligament ABC'
p493
aS'under arthroscopic control'
p494
asS'10.1016/j.jpeds.2011.06.026'
p495
(lp496
S'children with Down'
p497
aS'Down'
p498
aS'Down syndrome'
p499
aS'McGrath et al'
p500
aS'health care costs'
p501
aS'medical home'
p502
aS'coordination of care'
p503
aS'children'
p504
aS'national Down syndrome'
p505
aS'medical'
p506
aS'care for children'
p507
aS'medical care'
p508
aS'national Down'
p509
aS'twice as likely'
p510
aS'individuals with Down'
p511
aS'compared with children'
p512
aS'Children with Down'
p513
asS'10.1016/j.cell.2009.03.038'
p514
(lp515
S'plants were treated'
p516
aS'western blotting using'
p517
aS'anti GFP antibody'
p518
aS'5 mM SA'
p519
aS'0 5 mM'
p520
aS'PAGE and western'
p521
aS'reducing SDS PAGE'
p522
aS'analyzed by reducing'
p523
aS'confirmed equal loading'
p524
aS'proteins were analyzed'
p525
aS'analyzed by western'
p526
aS'100 M MG115'
p527
aS'Error bars represent'
p528
aS'hr Total protein'
p529
aS'24 hr Total'
p530
aS'western blotting'
p531
aS'NPR1 target genes'
p532
asS'10.1016/j.clinthera.2006.05.008'
p533
(lp534
S'6 month'
p535
aS'blind placebo controlled'
p536
aS'randomized double blind'
p537
aS'month randomized double'
p538
aS'double blind placebo'
p539
aS'6 month randomized'
p540
aS'sibutramine in obese'
p541
aS'sibutramine'
p542
aS'sibutramine group'
p543
aS'group at end'
p544
aS'placebo group'
p545
aS'obese Mexican adolescents'
p546
aS'placebo'
p547
aS'diet and exercise'
p548
aS'05 for all'
p549
aS'sibutramine group changed'
p550
aS'2 95 CI'
p551
asS'10.1016/j.amjsurg.2005.06.036'
p552
(lp553
S'surgical volume'
p554
aS'procedures per resident'
p555
aS'total major procedures'
p556
aS'80 hour work'
p557
aS'duty hour restrictions'
p558
aS'hour work week'
p559
aS'1997 to 2004'
p560
aS'duty hour standards'
p561
aS'M D term'
p562
aS'D term ends'
p563
aS'term ends June'
p564
aS'ends June 30'
p565
aS'Committee Surgery RRC'
p566
aS'Residency Review Committee'
p567
aS'Review Committee Surgery'
p568
aS'general surgery'
p569
aS'resident surgical procedures'
p570
asS'10.1053/j.oto.2011.01.004'
p571
(lp572
S'high tibial osteotomy'
p573
aS'open wedge'
p574
aS'open wedge high'
p575
aS'wedge high tibial'
p576
aS'treatment of unicompartmental'
p577
aS'loss of correction'
p578
aS'open wedge HTO'
p579
aS'version of figure'
p580
aS'case of disruption'
p581
aS'full weight bearing'
p582
aS'gonarthrosis even without'
p583
aS'bone substitute material'
p584
aS'grafts or bone'
p585
aS'without bone grafts'
p586
aS'successful in treatment'
p587
aS'unicompartmental gonarthrosis even'
p588
aS'even without bone'
p589
asS'10.1016/0305-0491(75)90014-0'
p590
(lp591
S'Alaskan king crab'
p592
aS'1 6 diphosphatase'
p593
aS'000 mol wt'
p594
aS'Alaskan king'
p595
aS'mol wt subunits'
p596
aS'single form'
p597
aS'40 000'
p598
aS'Alaskan'
p599
aS'pI'
p600
aS'functional differences between'
p601
aS'subunits from both'
p602
aS'sodium dodecyl sulfate'
p603
aS'values of pI'
p604
aS'halves by exposure'
p605
aS'altered to yield'
p606
aS'isoenzyme during thermal'
p607
aS'two 66 000'
p608
asS'10.1016/j.ejpn.2011.04.005'
p609
(lp610
S'acute movement disorders'
p611
aS'gastro oesophageal reflux'
p612
aS'neuroleptic malignant syndrome'
p613
aS'previously well children'
p614
aS'year old boy'
p615
aS'Leigh s disease'
p616
aS'acute necrotizing encephalopathy'
p617
aS'N methyl aspartate'
p618
aS'methyl aspartate receptor'
p619
aS'systemic lupus erythematosus'
p620
aS'after cardiopulmonary bypass'
p621
aS'gastro oesophageal'
p622
aS'brain iron accumulation'
p623
aS'secondary to gastro'
p624
aS'year old girl'
p625
aS'years of age'
p626
aS'intrathecal baclofen infusion'
p627
asS'10.1016/0048-9697(95)04756-5'
p628
(lp629
S'Sr from milk'
p630
aS'silica gel'
p631
aS'silica gel Si'
p632
aS'gel Si 60'
p633
aS'milk'
p634
aS'Sr'
p635
aS'PS DVB containing'
p636
aS'mol of C222'
p637
aS'crosslinked with divinylbenzene'
p638
aS'silica'
p639
aS'C222'
p640
aS'C222 sorbed'
p641
aS'resins'
p642
aS'Sr Y sorbed'
p643
aS'similarly to Sr'
p644
aS'efficiently by liquid'
p645
aS'directly and efficiently'
p646
asS'10.1016/0305-0491(74)90071-6'
p647
(lp648
S'tanner crab'
p649
aS'1 6 diphosphatase'
p650
aS'tanner crab muscle'
p651
aS'crab muscle FDPase'
p652
aS'tanner'
p653
aS'temperature'
p654
aS'tanner crab over'
p655
aS'high approaching physiological'
p656
aS'concentrations of AMP'
p657
aS'increase in affinity'
p658
aS'approaching physiological concentrations'
p659
aS'rise in pH'
p660
aS'sensitivity for AMP'
p661
aS'activity of FDPase'
p662
aS'inhibitor of activity'
p663
aS'regulation of muscle'
p664
aS'activity of tanner'
p665
asS'10.1016/j.cageo.2010.03.006'
p666
(lp667
S'Google Earth'
p668
aS'KML file'
p669
aS'virtual globe'
p670
aS'Lua programming language'
p671
aS'Google'
p672
aS'wind speed'
p673
aS'Python script file'
p674
aS'data input'
p675
aS'KML'
p676
aS'hydrodynamic'
p677
aS'Lua script'
p678
aS'AnuGA'
p679
aS'wind speed magnitude'
p680
aS'visualization'
p681
aS'used'
p682
aS'modeling'
p683
aS'help users'
p684
asS'10.1016/j.bbalip.2009.12.016'
p685
(lp686
S'metabolic syndrome'
p687
aS'mammalian cells'
p688
aS'induced cell death'
p689
aS'activated protein kinase'
p690
aS'involved in controlling'
p691
aS'involved in TAG'
p692
aS'flux of FA'
p693
aS'metabolic'
p694
aS'acetyl CoA carboxylase'
p695
aS'Kohlwein unpublished'
p696
aS'metabolic and regulatory'
p697
aS'novo phospholipid synthesis'
p698
aS'wild type cells'
p699
aS'3 phosphate acyltransferases'
p700
aS'TAG synthesis'
p701
aS'lead to lipid'
p702
aS'single celled'
p703
asS'e'
(lp704
S'Sr from milk'
p705
aS'silica gel'
p706
aS'silica gel Si'
p707
aS'gel Si 60'
p708
aS'milk'
p709
aS'Sr'
p710
aS'PS DVB containing'
p711
aS'mol of C222'
p712
aS'crosslinked with divinylbenzene'
p713
aS'silica'
p714
aS'C222'
p715
aS'C222 sorbed'
p716
aS'resins'
p717
aS'Sr Y sorbed'
p718
aS'similarly to Sr'
p719
aS'efficiently by liquid'
p720
aS'directly and efficiently'
p721
asS'd'
(lp722
S'Sr from milk'
p723
aS'silica gel'
p724
aS'silica gel Si'
p725
aS'gel Si 60'
p726
aS'milk'
p727
aS'Sr'
p728
aS'PS DVB containing'
p729
aS'mol of C222'
p730
aS'crosslinked with divinylbenzene'
p731
aS'silica'
p732
aS'C222'
p733
aS'C222 sorbed'
p734
aS'resins'
p735
aS'Sr Y sorbed'
p736
aS'similarly to Sr'
p737
aS'efficiently by liquid'
p738
aS'directly and efficiently'
p739
asS'10.1016/S1060-1872(10)80027-9'
p740
(lp741
S'patellar tendon'
p742
aS'intercondylar notch'
p743
aS'surgeon'
p744
aS'defect'
p745
aS'patellar'
p746
aS'hose and cold'
p747
aS'graft minimal trauma'
p748
aS'graft with minimal'
p749
aS'mentally and physically'
p750
aS'through full range'
p751
aS'graft over ligament'
p752
aS'femoral and tibial'
p753
aS'reliable for ACL'
p754
aS'anterior cruciate ligament'
p755
aS'Before wound closure'
p756
aS'graft with contoured'
p757
aS'examination and meniscus'
p758
asS'10.1016/j.febslet.2009.09.047'
p759
(lp760
S'1 and HSC70'
p761
aS'interaction between BAG'
p762
aS'breast cancer cell'
p763
aS'breast cancer'
p764
aS'BAG 1 HSC70'
p765
aS'interaction between'
p766
aS'1 HSC70 interaction'
p767
aS'domain of BAG'
p768
aS'BAG'
p769
aS'MINT MINT MINT'
p770
aS'breast cancer cells'
p771
aS'1 HSC70 binding'
p772
aS'interaction of BAG'
p773
aS'1 C terminal'
p774
aS'BAG 1 peptides'
p775
aS'domain of HSC70'
p776
aS'amino acid residues'
p777
asS'10.1016/j.actbio.2011.03.001'
p778
(lp779
S'silk fibroin'
p780
aS'silk fibroin films'
p781
aS'water insoluble silk'
p782
aS'blended with silk'
p783
aS'silk fibroin solution'
p784
aS'insoluble silk fibroin'
p785
aS'surface of silk'
p786
aS'solid silk fibroin'
p787
aS'70 antibody cast'
p788
aS'SF 70 antibody'
p789
aS'half solid silk'
p790
aS'dried for 70h'
p791
aS'SF B antibody'
p792
aS'antibody directly blended'
p793
aS'B antibody directly'
p794
aS'silk'
p795
aS'secondary antibody'
p796
asS'10.1016/j.cell.2011.06.042'
p797
(lp798
S'MinD'
p799
aS'four stranded sheet'
p800
aS'anti MinCD domain'
p801
aS'stranded sheet structure'
p802
aS'bound to MinD'
p803
aS'six stranded'
p804
aS'secondary structure content'
p805
aS'six stranded sheet'
p806
aS'four stranded'
p807
aS'interaction with MinD'
p808
aS'data not shown'
p809
aS'1 strand'
p810
aS'two MinD dimers'
p811
aS'contact helix'
p812
aS'activity of MinD'
p813
aS'90 with respect'
p814
aS'anti MinCD domains'
p815
asS'x'
(lp816
S'Sr from milk'
p817
aS'silica gel'
p818
aS'silica gel Si'
p819
aS'gel Si 60'
p820
aS'milk'
p821
aS'Sr'
p822
aS'PS DVB containing'
p823
aS'mol of C222'
p824
aS'crosslinked with divinylbenzene'
p825
aS'silica'
p826
aS'C222'
p827
aS'C222 sorbed'
p828
aS'resins'
p829
aS'Sr Y sorbed'
p830
aS'similarly to Sr'
p831
aS'efficiently by liquid'
p832
aS'directly and efficiently'
p833
asS'10.1016/S0168-9525(01)02618-X'
p834
(lp835
S'cell death machinery'
p836
aS'Bcl 2 family'
p837
aS'2 family members'
p838
aS'BH3 only proteins'
p839
aS'cell death'
p840
aS'FADD and caspase'
p841
aS'Bax and Bak'
p842
aS'anti apoptotic Bcl'
p843
aS'programmed cell death'
p844
aS'Bcl 2 related'
p845
aS'2 related proteins'
p846
aS'structural and functional'
p847
aS'pro apoptotic Bcl'
p848
aS'activation of caspases'
p849
aS'Bcl 2 Bcl'
p850
aS'2 Bcl XL'
p851
aS'pro apoptotic members'
p852
asS'10.1016/j.actatropica.2010.02.001'
p853
(lp854
S'species and molecular'
p855
aS'Republic of Benin'
p856
aS'two molecular forms'
p857
aS'species and forms'
p858
aS'Benin'
p859
aS'mean annual rainfall'
p860
aS'complex'
p861
aS'M form'
p862
aS'S forms'
p863
aS'ecological and behavioral'
p864
aS'molecular forms'
p865
aS'species'
p866
aS'West Africa'
p867
aS'coastal Guinean bioclimatic'
p868
aS'two molecular'
p869
aS'te d Ivoire'
p870
aS'vector control interventions'
p871
asS'10.1016/j.actbio.2011.03.016'
p872
(lp873
S'bioactive glass scaffolds'
p874
aS'borate bioactive glass'
p875
aS'borate 13 93B3'
p876
aS'silicate 13 93'
p877
aS'tissue engineering'
p878
aS'HA like material'
p879
aS'93 bioactive glass'
p880
aS'13 93 bioactive'
p881
aS'12weeks post implantation'
p882
aS'cell seeded agarose'
p883
aS'93B3 bioactive glass'
p884
aS'13 93B3 bioactive'
p885
aS'new bone formation'
p886
aS'45S5 bioactive glass'
p887
aS'borosilicate 13 93B1'
p888
aS'13 93 glass'
p889
aS'polymer foam replication'
p890
as.